The FINANCIAL — Elekta (EKTA-B.ST), Royal Philips and The Netherlands Cancer Institute, (NKI, Amsterdam, the Netherlands) on April 17 announced the installation of a high-field (1.5 Tesla) MR-guided ...
Elekta EKTAY recently announced that its Elekta Evo CT-Linac has received 510(k) clearance from the FDA, making the system ...
HOUSTON--(BUSINESS WIRE)--Regulatory News: The University of Texas MD Anderson Cancer Center has signed a deal with Elekta (EKTA-B.ST) to acquire Elekta Infinity ...
ATLANTA — With much pomp and circumstance, Elekta (Stockholm, Sweden) unveiled its Versa HD, an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of ...
In order to deliver Adaptive Radiation Therapy (ART) for cancer, Elekta, a global leader in precision radiation therapy, will launch an advanced AI-enabled CT-Linac (linear accelerator) by the name ...
GUWAHATI, India, Dec. 5, 2025 /PRNewswire/ -- Elekta announced the introduction of its latest linear accelerator (linac), Evo*, to the Indian market. Already launched in Europe and other regions, Evo ...
Elekta, a company based in Sweden, is one of the world's leaders in developing some of the most cutting-edge cancer treatment technologies — and Mary Bird Perkins Cancer Center has worked with them ...
DUBLIN, Dec. 19, 2019 /PRNewswire/ -- The "Medical Linear Accelerators Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The Global Medical ...
ATLANTA - Elekta (EKTA-B.ST) announced that its Elekta Evo* CT-Linac has today received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This milestone makes the system available to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results